Medicare Enrolled
Dr. Matthew Banks, DO
Neurology · Fayetteville, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Banks from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Banks?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Banks
Dr. Matthew Banks is a neurology specialist in Fayetteville, NC, with 11 years of NPI registration. Based on federal Medicare data, Dr. Banks performed 1,262 Medicare services across 862 unique beneficiaries.
Between the years covered by Open Payments, Dr. Banks received a total of $9,565 from 53 pharmaceutical and/or device companies across 468 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Banks is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 16% volume in NC
$9,565 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,262
Medicare services
Top 16% in NC for neurology
862
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~115 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
547 | $88 | $243 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
156 | $67 | $174 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
126 | $121 | $320 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
108 | $71 | $190 |
| New patient office visit, complex (60-74 min) | 102 | $156 | $424 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
49 | $1 | $5 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
36 | $11 | $27 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
35 | $154 | $410 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
33 | $284 | $715 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
16 | $216 | $560 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
15 | $9 | $25 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
14 | $135 | $346 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 13 | $204 | $533 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
12 | $121 | $344 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,565
Total received (2018-2024)
Avg $1,366/year across 7 years
Top 23% in NC for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
468
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,545 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$20 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,592
2023
$3,088
2022
$79
2021
$199
2020
$208
2019
$302
2018
$96
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$399
Janssen Pharmaceuticals, Inc
$388
Biogen, Inc.
$366
TG Therapeutics, Inc.
$350
EMD Serono, Inc.
$335
Teva Pharmaceuticals USA, Inc.
$304
Alexion Pharmaceuticals, Inc.
$274
Novartis Pharmaceuticals Corporation
$273
UCB, Inc.
$250
Lundbeck LLC
$248
SK Life Science, Inc.
$217
Amneal Pharmaceuticals LLC
$201
Eisai Inc.
$182
Celgene Corporation
$182
PFIZER INC.
$168
Neurelis, Inc.
$166
Lilly USA, LLC
$166
SCILEX PHARMACEUTICALS INC.
$133
ARGENX US, INC.
$118
Genentech USA, Inc.
$110
Otsuka America Pharmaceutical, Inc.
$107
Ipsen Biopharmaceuticals, Inc
$87
BANNER LIFE SCIENCES, LLC
$79
JAZZ PHARMACEUTICALS INC.
$65
ACADIA Pharmaceuticals Inc
$59
Amgen Inc.
$54
Neurocrine Biosciences, Inc.
$47
Averitas Pharma Inc.
$40
Mallinckrodt Hospital Products Inc.
$37
Takeda Pharmaceuticals U.S.A., Inc.
$25
LivaNova USA, Inc.
$22
Octapharma USA, Inc.
$21
Grifols USA, LLC
$21
Merz Pharmaceuticals, LLC
$20
Xeris Pharmaceuticals, Inc.
$17
Otsuka Pharmaceutical Development & Commercialization, Inc.
$16
Nevro Corp.
$15
Kedrion Biopharma, Inc.
$15
Aucta Pharmaceuticals, Inc.
$14
Top 3 companies account for 20.6% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$639
Janssen Pharmaceuticals, Inc
$600
Novartis Pharmaceuticals Corporation
$563
Alexion Pharmaceuticals, Inc.
$497
Lilly USA, LLC
$422
ABBVIE INC.
$399
AbbVie Inc.
$372
Amneal Pharmaceuticals LLC
$368
SK Life Science, Inc.
$366
UCB, Inc.
$364
TG Therapeutics, Inc.
$350
Lundbeck LLC
$340
EMD Serono, Inc.
$335
PFIZER INC.
$330
Celgene Corporation
$330
Teva Pharmaceuticals USA, Inc.
$323
Amgen Inc.
$315
ARGENX US, INC.
$189
ACADIA Pharmaceuticals Inc
$189
Neurocrine Biosciences, Inc.
$183
Eisai Inc.
$182
Neurelis, Inc.
$166
Ipsen Biopharmaceuticals, Inc
$153
Genentech USA, Inc.
$150
Otsuka America Pharmaceutical, Inc.
$148
SCILEX PHARMACEUTICALS INC.
$133
Adamas Pharmaceuticals, Inc.
$123
TG THERAPEUTICS, INC.
$95
JAZZ PHARMACEUTICALS INC.
$91
BANNER LIFE SCIENCES, LLC
$79
Octapharma USA, Inc.
$72
Janssen Scientific Affairs, LLC
$69
Kyowa Kirin, Inc.
$68
Grifols USA, LLC
$65
Brainsway USA INC
$49
MDD US Operations, LLC
$44
Averitas Pharma Inc.
$40
Acorda Therapeutics, Inc
$37
Mallinckrodt Hospital Products Inc.
$37
Xeris Pharmaceuticals, Inc.
$35
E.R. Squibb & Sons, L.L.C.
$34
PORTOLA PHARMACEUTICALS, INC.
$26
Takeda Pharmaceuticals U.S.A., Inc.
$25
LivaNova USA, Inc.
$22
Alnylam Pharmaceuticals Inc.
$20
Merz Pharmaceuticals, LLC
$20
ADVANCED RESPIRATORY, INC
$19
Mitsubishi Tanabe Pharma America, Inc.
$16
Otsuka Pharmaceutical Development & Commercialization, Inc.
$16
Nevro Corp.
$15
Kedrion Biopharma, Inc.
$15
Aucta Pharmaceuticals, Inc.
$14
GENZYME CORPORATION
$13
Top 3 companies account for 18.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMYVID · ANDEXXA · AUSTEDO · Aimovig · Albuked · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Briviact · COMIRNATY · Dysport · EMGALITY · EPIDIOLEX · GOCOVRI · Gamunex-C · HYQVIA · INBRIJA · INGREZZA · INVEGA SUSTENNA · KESIMPTA · KEVEYIS · LEQEMBI · LEQVIO · Leqembi · Motpoly XR · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCREVUS · ONFI · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PAXLOVID · POMPE - DISEASE · QULIPTA · QUTENZA · REXULTI · RYTARY · Radicava · Rystiggo · SOLIRIS · SPRAVATO · Senza · TYSABRI · The Vest System Model 105 Home Care · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Xembify · Xeomin · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
27
Per 100K population
8.0
County median income
$58,780
Nearest hospital
FAYETTEVILLE NC VA MEDICAL CENTER
6.9 mi
6.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Banks is a clinical cardiology specialist, with above-average Medicare volume (top 16% in NC), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Banks experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Banks performed 547 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Banks receive payments from pharmaceutical companies?
Yes. Dr. Banks received a total of $9,565 from 53 companies across 468 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Banks's costs compare to other neurologists in Fayetteville?
Dr. Banks's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Banks) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Fayetteville
Browse neurologists in Fayetteville ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NC
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NC
Which NC neurologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology